Patient Registry to Observe Outcomes Following Implantation of the VariLift Interbody Fusion Device
VariLift Lumbar and Cervical Patient Registry
1 other identifier
observational
69
1 country
3
Brief Summary
The registry has been designed as a prospective, observational program for patients undergoing lumbar or cervical fusion using VariLift device with the ultimate goal to aid in the development of strategic treatment pathways and improved patient care. All patients who agree to participate in the registry will sign an informed consent form and subsequently be treated by their surgeon with the VariLift device. Potential treatment procedures include bilateral posterior lumbar interbody fusion (PLIF), unilateral transforaminal lumbar interbody fusion (TLIF), or bilateral anterior lumbar interbody fusion (ALIF) for the lumbar spine, or cervical unilateral or bilateral ACDF procedure. Surgical procedures can be performed in either an inpatient or outpatient facility. It is anticipated that the VariLift devices will improve patient outcomes and lead to the development of treatment pathways to improve patient care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2013
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 6, 2013
CompletedFirst Posted
Study publicly available on registry
September 17, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedResults Posted
Study results publicly available
April 14, 2016
CompletedMay 17, 2016
April 1, 2016
2.3 years
September 6, 2013
January 6, 2016
April 14, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Oswestry Disability Index (ODI)/Neck Disability Index (NDI) Score Range 0-50
ODI/NDI Score Range: 0-50 0-4 No disability 5-14 Mild disability 15-24 Moderate disability 25-34 Severe disability \>34 Complete disability
Pre-operative and Post-operative 12 months post-operative
Change in VAS Pain
VAS Pain comparison Preoperative vs post-operative of greater than or equal to 6. VAS PAIN SEVERITY SCALE ranges from 0-10. A score of zero (0) means 'no pain' and a ten (10) means 'worst imaginable pain'
Pre-operative and Post-operative 12 months
Secondary Outcomes (1)
Radiological Assessment
Post-operative follow up
Eligibility Criteria
Patients undergoing spinal fusion using VariLift lumbar or cervical devices must be screened by the investigating surgeon for eligibility into the registry using the primary diagnosis parameters and the inclusion/exclusion criteria. In addition physicians must follow the associated VariLift Instructions for Use.
You may qualify if:
- Patient is undergoing a procedure with unilateral or bilateral placement of VariLift
- This is the first surgery at the index level
- Patient has understood and signed the informed consent
- Patient is skeletally mature
You may not qualify if:
- Revision Surgery
- Is a Worker's Compensation Case
- Infection at the operative site
- Sustained trauma with instability
- Sustained fracture of the vertebra at any of the lumbar spinal levels
- Has a primary diagnosis of degenerative or isthmic spondylolisthesis greater than Grade 1
- Physically or mentally compromised (i.e., being currently treated for a psychiatric disorder, senile dementia, Alzheimer's disease, presence of alcohol or drug abuse)
- Has a diagnosed systemic disease that would affect the subject's welfare or overall outcome of the clinical study (i.e., moderate to severe osteoporosis, Paget's disease, renal osteodystrophy, metastasis to vertebrae, adult onset diabetes, active rheumatoid arthritis, etc.)
- Is an immunologically suppressed or receiving steroid in excess of usual doses
- Is obese (as defined by a Body Mass Index (BMI) of \> 40 kg/m2 (BMI equals (weight in pounds x 703) / (height in inches x height in inches))
- Has disabling and daily narcotic dependency greater than 18 months
- Has a known malignancy
- Has a known allergy to metal implants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wenzel Spinelead
Study Sites (3)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Foundation Surgical Hospital
San Antonio, Texas, 78229, United States
Methodist Hospital
San Antonio, Texas, 78229, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Director, Quality & Regulatory Affairs
- Organization
- Wenzel Spine, Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Warren Neely, MD
The Methodist Hospital Research Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2013
First Posted
September 17, 2013
Study Start
June 1, 2013
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
May 17, 2016
Results First Posted
April 14, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share
Data will not be shared